Several key signaling pathways, including the AKT, RAS, NFκB, WNT-β-catenin, and TGF-β signaling pathways, have been identified as responsible for initiating and developing cHCC-ICC [23]. The gene discussed is TGFB1; the disease is intrahepatic cholangiocarcinoma.